CHIEF EXECUTIVE OFFICER
Wed, May 1, 2024
May 1
70,051 shares @ $17.88
Decreased holdings by -9.70%
Largest trade (out of 185)
Planned (10b5-1)Large TradePositive 90D History
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
64% win rate · +2.3% median edge vs SPY (14 trades, 90-day · small sample)
Price 30% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology